1. Granulocyte Transfusion
- Author
-
Sierra C. Simmons, Elizabeth M. Staley, Tobias Cohen, and Huy P. Pham
- Subjects
medicine.medical_specialty ,Innate immune system ,business.industry ,Biochemistry (medical) ,Clinical Biochemistry ,Granulocyte ,Neutropenia ,medicine.disease ,Clinical trial ,medicine.anatomical_structure ,medicine ,Neutrophil dysfunction ,In patient ,Clinical efficacy ,Intensive care medicine ,business ,Severe neutropenia - Abstract
Neutrophils are an integral component of the innate immune system and key regulators of cell-mediated defense against bacterial and fungal pathogens. The potential of granulocyte transfusions has been investigated to temporarily replenish innate immune function to prevent and/or treat infections in patients with severe neutropenia or neutrophil dysfunction. However, evidence has been largely theoretical, experimental, and/or inconclusive. Clinical efficacy has yet to be confirmed by large-scale randomized controlled clinical trials. Performing such trials has been hampered by low granulocyte collection yield and poor patient accrual. We provide a practical summary of the current literature surrounding the practice of granulocyte transfusion.
- Published
- 2021